Percepta Genomic Sequencing Classifier May Improve Clinical Decision Making Regarding Lung Nodules
Researchers present data that demonstrate how the Percepta Genomic Sequencing Classifier can enhance care decisions regarding lung nodules.
Diagnosis & Disease Information
Prognostic Understanding Influences Patients’ Lung Cancer Care Decisions at the End of Life
Researchers assessed the associations between patients’ understanding of their prognosis and their end-of-life care decisions.
Multidisciplinary Response Program Improves Follow-up, Referrals for Suspicious Lung Nodules
Researchers present data on a program designed to increase completion rates among patients with suspicious lung nodules on screening CT.
Prediction Model Assesses Risk of Brain Metastasis in Patients With Non-Small Cell Lung Cancer
Researchers present their prediction model for assessing risk of brain metastases in patients with non-small cell lung cancer.
Mobile Wearable Devices Show Some Sleep Disturbances During Multiple Myeloma Treatment
Younger patients had a significant decrease in sleep time on days they received dexamethasone.
Age and Stage at Breast Cancer Diagnosis Don’t Account for Racial Disparities in Distant Metastases
Black patients were more likely than White patients to have distant metastases.
MRD Negativity Linked to Better Survival After Venetoclax-Azacitidine in Acute Myeloid Leukemia
Improvements were seen in event-free and overall survival.
Abemaciclib Plus Endocrine Therapy Deemed Beneficial in High-Risk Early Breast Cancer After Neoadjuvant Chemo
The combination improved invasive disease-free survival and distant relapse-free survival.
Ivosidenib Plus Venetoclax, With or Without Azacitidine, Appears Effective in IDH1-Mutated Myeloid Malignancies
The 1-year overall survival rate was 71%.
Combination Therapy Shows Promise in Patients With Ultra High-Risk Multiple Myeloma, PCL
Researchers sought to determine whether a combination therapy with bortezomib-augmented ASCT would have efficacy in patients with ultra high-risk multiple myeloma or plasma cell leukemia.
- Loading...
Loading...
Loading... 
Loading...